Friday, August 16, 2024 7:02:08 PM
I’m not greedy, I’m ok wetting my beak
Look, truth be told, I wasn’t crazy about the mention of the concept of nondilutive management compensation awards.
I’m not sure what the reality was, however I’ve worked in big corporations and have seen “compensation plans, bonuses, options repricings, etc” that always seem to have outsized benefits to the higher ups, and even some benefits at my former levels, so we all live in glass houses so to speak.
The management structure of the FUDsters employers have similar outsized benefits at the top levels, just a much more serious severance package
Seriously though, I would love to have a great return from the nwbo investment but honestly the benefits to humanity of making a breakthrough advancement in the fight against cancer, that has taken our dearest loved ones and friends and all peoples, is the much more important return on investment.
We are all subject to the suffering that cancer inflicts indirectly and directly.
Look, truth be told, I wasn’t crazy about the mention of the concept of nondilutive management compensation awards.
I’m not sure what the reality was, however I’ve worked in big corporations and have seen “compensation plans, bonuses, options repricings, etc” that always seem to have outsized benefits to the higher ups, and even some benefits at my former levels, so we all live in glass houses so to speak.
The management structure of the FUDsters employers have similar outsized benefits at the top levels, just a much more serious severance package
Seriously though, I would love to have a great return from the nwbo investment but honestly the benefits to humanity of making a breakthrough advancement in the fight against cancer, that has taken our dearest loved ones and friends and all peoples, is the much more important return on investment.
We are all subject to the suffering that cancer inflicts indirectly and directly.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
